New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy

For decades, intensive chemotherapy (IC) has been considered the best therapeutic option for treating acute myeloid leukemia (AML), with no curative option available for patients who are not eligible for IC or who have had failed IC. Over the last few years, several new drugs have enriched the thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreozzi, Fabio, Massaro, Fulvio, Wittnebel, Sebastian, Spilleboudt, Chloé, Lewalle, Philippe, Salaroli, Adriano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999556/
https://www.ncbi.nlm.nih.gov/pubmed/35409248
http://dx.doi.org/10.3390/ijms23073887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999556/
https://www.ncbi.nlm.nih.gov/pubmed/35409248
http://dx.doi.org/10.3390/ijms23073887

Ejemplares similares